WO2016072392A8 - タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 - Google Patents
タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 Download PDFInfo
- Publication number
- WO2016072392A8 WO2016072392A8 PCT/JP2015/080934 JP2015080934W WO2016072392A8 WO 2016072392 A8 WO2016072392 A8 WO 2016072392A8 JP 2015080934 W JP2015080934 W JP 2015080934W WO 2016072392 A8 WO2016072392 A8 WO 2016072392A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tau protein
- therapeutic
- diseases caused
- preventive
- food composition
- Prior art date
Links
- 102000013498 tau Proteins Human genes 0.000 title abstract 9
- 108010026424 tau Proteins Proteins 0.000 title abstract 9
- 208000008425 Protein deficiency Diseases 0.000 title abstract 6
- 201000010099 disease Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 230000003449 preventive effect Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000014616 translation Effects 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000006806 disease prevention Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2015344361A AU2015344361B2 (en) | 2014-11-04 | 2015-11-02 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
RU2017118158A RU2742658C2 (ru) | 2014-11-04 | 2015-11-02 | Средство, стимулирующее продукцию тау-белка, и терапевтическое или профилактическое средство и терапевтическая или профилактическая пищевая композиция, предназначенные для лечения заболеваний, вызванных дефицитом тау-белка |
KR1020177015237A KR101948913B1 (ko) | 2014-11-04 | 2015-11-02 | 타우 단백질 생산 촉진제, 타우 단백질의 결핍에 기인한 질환의 치료약·예방약 및 치료용·예방용 식품 조성물 |
EP15856572.1A EP3216456B1 (en) | 2014-11-04 | 2015-11-02 | Tau protein production accelerator, and therapeutic or preventive agent for diseases caused by tau protein deficiency |
BR112017008734-0A BR112017008734B1 (pt) | 2014-11-04 | 2015-11-02 | Acelerador de produção de proteína tau e agente preventivo ou terapêutico e composição alimentícia preventiva ou terapêutica para doenças causadas por deficiência de proteína tau |
CN201580045874.1A CN106794199B (zh) | 2014-11-04 | 2015-11-02 | Tau蛋白产生促进剂、起因于缺乏Tau蛋白的疾病的治疗药/预防药 |
CA2964316A CA2964316C (en) | 2014-11-04 | 2015-11-02 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
US15/523,767 US10398740B2 (en) | 2014-11-04 | 2015-11-02 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
PH12017500743A PH12017500743A1 (en) | 2014-11-04 | 2017-04-21 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
US16/513,927 US10576108B2 (en) | 2014-11-04 | 2019-07-17 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014-223977 | 2014-11-04 | ||
JP2014223977A JP6321521B2 (ja) | 2014-11-04 | 2014-11-04 | タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/523,767 A-371-Of-International US10398740B2 (en) | 2014-11-04 | 2015-11-02 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
US16/513,927 Division US10576108B2 (en) | 2014-11-04 | 2019-07-17 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016072392A1 WO2016072392A1 (ja) | 2016-05-12 |
WO2016072392A8 true WO2016072392A8 (ja) | 2017-03-30 |
Family
ID=55909117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/080934 WO2016072392A1 (ja) | 2014-11-04 | 2015-11-02 | タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 |
Country Status (12)
Country | Link |
---|---|
US (2) | US10398740B2 (ja) |
EP (1) | EP3216456B1 (ja) |
JP (1) | JP6321521B2 (ja) |
KR (1) | KR101948913B1 (ja) |
CN (1) | CN106794199B (ja) |
AU (1) | AU2015344361B2 (ja) |
BR (1) | BR112017008734B1 (ja) |
CA (1) | CA2964316C (ja) |
PH (1) | PH12017500743A1 (ja) |
RU (1) | RU2742658C2 (ja) |
TW (1) | TWI689311B (ja) |
WO (1) | WO2016072392A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017025019A (ja) * | 2015-07-21 | 2017-02-02 | Well Stone 有限会社 | アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 |
CN110191715B (zh) | 2017-03-21 | 2020-11-10 | 井石有限会社 | 皮肤损伤治疗剂的制造方法及皮肤损伤治疗剂 |
TW201929877A (zh) * | 2017-12-29 | 2019-08-01 | 大江生醫股份有限公司 | 地龍蛋白用於製造保護腦神經細胞醫藥組成物之用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5728007A (en) * | 1980-07-29 | 1982-02-15 | Mitsuo Ishikura | Preparation of colorless, transparent and tasteless earthworm extract |
JPS59216572A (ja) * | 1983-05-20 | 1984-12-06 | Yoichi Ishii | ミミズ蛋白及び脂質健康食品 |
KR900012617A (ko) * | 1987-10-28 | 1990-09-01 | 요오이찌 이시이 | 혈전증 치료제 및 그 제조방법 |
JPH02215723A (ja) * | 1989-02-15 | 1990-08-28 | Eimei:Kk | 血圧調節剤 |
RU2177784C2 (ru) | 1999-06-01 | 2002-01-10 | Пермское научно-производственное объединение "Биомед" | Энтеральный препарат, содержащий экстракт биомассы красного калифорнийского дождевого червя eisenia foetidae в виде таблеток "вермин" |
ITRM20050045A1 (it) * | 2005-02-02 | 2006-08-03 | Consiglio Nazionale Ricerche | Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi. |
CN1873005A (zh) * | 2005-06-02 | 2006-12-06 | 中国科学院生物物理研究所 | 蚯蚓微管结合蛋白Tau、其编码基因及其应用 |
CN101095697A (zh) * | 2006-06-28 | 2008-01-02 | 李振国 | 水蛭和/或地龙分子量5800道尔顿以下的提取物 |
CN101543512B (zh) * | 2008-03-28 | 2012-03-28 | 井石有限会社 | 蚯蚓干燥粉末的生产方法 |
PL2276485T3 (pl) * | 2008-04-24 | 2014-12-31 | Bristol Myers Squibb Co | Stosowanie epotilonu D w leczeniu chorób związanych z Tau, w tym choroby Alzheimera |
JP4886017B2 (ja) * | 2009-10-13 | 2012-02-29 | Well Stone 有限会社 | ミミズ乾燥粉末の製造方法 |
JP4808822B1 (ja) | 2011-04-11 | 2011-11-02 | Well Stone 有限会社 | ミミズ乾燥粉末の製造方法 |
KR101198192B1 (ko) | 2011-04-11 | 2012-11-12 | 웰 스톤 유겐가이샤 | 지렁이 건조 분말의 제조 방법 |
CN103702661B (zh) | 2011-07-29 | 2015-10-07 | 井石有限会社 | 使用了蚯蚓干燥粉末的酪氨酸酶抑制剂及其制造方法 |
JP5856725B2 (ja) * | 2011-08-02 | 2016-02-10 | 和夫 酒井 | うつ病治療用または予防用医薬組成物 |
CN103251884B (zh) * | 2013-05-03 | 2015-02-18 | 杨文明 | 治疗阿尔茨海默病的中药及其制备方法和应用 |
CN103550537B (zh) * | 2013-11-10 | 2014-08-06 | 孟晓彬 | 一种治疗阿尔茨海默病的中药制剂及制备方法 |
BR112016014981B1 (pt) * | 2014-01-20 | 2021-10-13 | Well Stone Co | Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina |
-
2014
- 2014-11-04 JP JP2014223977A patent/JP6321521B2/ja active Active
-
2015
- 2015-11-02 US US15/523,767 patent/US10398740B2/en active Active
- 2015-11-02 KR KR1020177015237A patent/KR101948913B1/ko active IP Right Grant
- 2015-11-02 EP EP15856572.1A patent/EP3216456B1/en active Active
- 2015-11-02 CA CA2964316A patent/CA2964316C/en active Active
- 2015-11-02 CN CN201580045874.1A patent/CN106794199B/zh active Active
- 2015-11-02 AU AU2015344361A patent/AU2015344361B2/en active Active
- 2015-11-02 BR BR112017008734-0A patent/BR112017008734B1/pt active IP Right Grant
- 2015-11-02 WO PCT/JP2015/080934 patent/WO2016072392A1/ja active Application Filing
- 2015-11-02 RU RU2017118158A patent/RU2742658C2/ru active
- 2015-11-03 TW TW104136172A patent/TWI689311B/zh active
-
2017
- 2017-04-21 PH PH12017500743A patent/PH12017500743A1/en unknown
-
2019
- 2019-07-17 US US16/513,927 patent/US10576108B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2015344361A1 (en) | 2017-06-15 |
TW201630616A (zh) | 2016-09-01 |
JP2016088877A (ja) | 2016-05-23 |
CA2964316C (en) | 2024-05-14 |
EP3216456B1 (en) | 2020-09-16 |
AU2015344361B2 (en) | 2020-10-01 |
WO2016072392A1 (ja) | 2016-05-12 |
TWI689311B (zh) | 2020-04-01 |
CN106794199A (zh) | 2017-05-31 |
US20170348357A1 (en) | 2017-12-07 |
US20190365826A1 (en) | 2019-12-05 |
EP3216456A1 (en) | 2017-09-13 |
BR112017008734B1 (pt) | 2021-11-23 |
CA2964316A1 (en) | 2016-05-12 |
KR101948913B1 (ko) | 2019-02-15 |
EP3216456A4 (en) | 2018-05-09 |
US10398740B2 (en) | 2019-09-03 |
PH12017500743A1 (en) | 2017-10-09 |
BR112017008734A2 (ja) | 2018-02-27 |
RU2017118158A3 (ja) | 2019-06-06 |
CN106794199B (zh) | 2021-03-23 |
JP6321521B2 (ja) | 2018-05-09 |
KR20170072348A (ko) | 2017-06-26 |
RU2017118158A (ru) | 2018-12-05 |
RU2742658C2 (ru) | 2021-02-09 |
US10576108B2 (en) | 2020-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
WO2017095944A8 (en) | Methods and compositions relating to chondrisomes from blood products | |
WO2015018380A3 (en) | Therapeutic nanoparticles and the preparation methods thereof | |
WO2016190683A8 (ko) | 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
WO2017053868A8 (en) | C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses | |
EP3643723A4 (en) | NEW PEPTIDE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF EYE DISEASES WITH SUCH NEW PEPTIDE AS THE ACTIVE SUBSTANCE | |
EP4218823A3 (en) | Novel polymeric hgh prodrugs | |
WO2016004404A3 (en) | Gls1 inhibitors for treating disease | |
WO2016190682A3 (ko) | 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
WO2016004413A3 (en) | Gls1 inhibitors for treating disease | |
EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
WO2017121646A8 (en) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
PH12017500743A1 (en) | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency | |
PH12016501205A1 (en) | Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency | |
EP3643302A4 (en) | COMPOSITION COMPRISING A SESQUITERPENE DERIVATIVE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MUSCULAR DISEASES | |
MX2017004760A (es) | Formulacion esterilizada por calor que comprende quitosan y proceso para preparacion de la misma. | |
WO2016006975A3 (en) | Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof | |
WO2016006974A3 (en) | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof | |
WO2011118957A3 (ko) | 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물 | |
PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
WO2015044961A3 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
EP3603656A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF GYNECOLOGICAL DISEASES WITH EXTRACT OF SARCODON IMBRICATUS AS THE ACTIVE SUBSTANCE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15856572 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2964316 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15523767 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112017008734 Country of ref document: BR |
|
REEP | Request for entry into the european phase |
Ref document number: 2015856572 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20177015237 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2017118158 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2015344361 Country of ref document: AU Date of ref document: 20151102 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 112017008734 Country of ref document: BR Kind code of ref document: A2 Effective date: 20170426 |